These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 9418135)

  • 1. Selection of a diverse TCR repertoire in response to an Epstein-Barr virus-encoded transactivator protein BZLF1 by CD8+ cytotoxic T lymphocytes during primary and persistent infection.
    Silins SL; Cross SM; Elliott SL; Pye SJ; Burrows JM; Moss DJ; Misko IS
    Int Immunol; 1997 Nov; 9(11):1745-55. PubMed ID: 9418135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominant cytotoxic T lymphocyte response to the immediate-early trans-activator protein, BZLF1, in persistent type A or B Epstein-Barr virus infection.
    Elliott SL; Pye SJ; Schmidt C; Cross SM; Silins SL; Misko IS
    J Infect Dis; 1997 Oct; 176(4):1068-72. PubMed ID: 9333169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis.
    Silins SL; Cross SM; Elliott SL; Pye SJ; Burrows SR; Burrows JM; Moss DJ; Argaet VP; Misko IS
    J Exp Med; 1996 Nov; 184(5):1815-24. PubMed ID: 8920869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDR3α drives selection of the immunodominant Epstein Barr virus (EBV) BRLF1-specific CD8 T cell receptor repertoire in primary infection.
    Kamga L; Gil A; Song I; Brody R; Ghersi D; Aslan N; Stern LJ; Selin LK; Luzuriaga K
    PLoS Pathog; 2019 Nov; 15(11):e1008122. PubMed ID: 31765434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response.
    Steven NM; Annels NE; Kumar A; Leese AM; Kurilla MG; Rickinson AB
    J Exp Med; 1997 May; 185(9):1605-17. PubMed ID: 9151898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen.
    Burrows SR; Silins SL; Moss DJ; Khanna R; Misko IS; Argaet VP
    J Exp Med; 1995 Dec; 182(6):1703-15. PubMed ID: 7500015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
    Hill AB; Lee SP; Haurum JS; Murray N; Yao QY; Rowe M; Signoret N; Rickinson AB; McMichael AJ
    J Exp Med; 1995 Jun; 181(6):2221-8. PubMed ID: 7539044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr Virus Epitope-Major Histocompatibility Complex Interaction Combined with Convergent Recombination Drives Selection of Diverse T Cell Receptor α and β Repertoires.
    Gil A; Kamga L; Chirravuri-Venkata R; Aslan N; Clark F; Ghersi D; Luzuriaga K; Selin LK
    mBio; 2020 Mar; 11(2):. PubMed ID: 32184241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infection.
    Silins SL; Cross SM; Krauer KG; Moss DJ; Schmidt CW; Misko IS
    J Clin Invest; 1998 Oct; 102(8):1551-8. PubMed ID: 9788968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: implications for molecular mimicry in autoimmune disease.
    Misko IS; Cross SM; Khanna R; Elliott SL; Schmidt C; Pye SJ; Silins SL
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2279-84. PubMed ID: 10051632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus.
    Bogedain C; Wolf H; Modrow S; Stuber G; Jilg W
    J Virol; 1995 Aug; 69(8):4872-9. PubMed ID: 7609055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytes.
    Pepperl S; Benninger-Döring G; Modrow S; Wolf H; Jilg W
    J Virol; 1998 Nov; 72(11):8644-9. PubMed ID: 9765404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein-Barr virus in healthy virus carriers.
    Benninger-Döring G; Pepperl S; Deml L; Modrow S; Wolf H; Jilg W
    Virology; 1999 Nov; 264(2):289-97. PubMed ID: 10562493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The BZLF1 homolog of an Epstein-Barr-related gamma-herpesvirus is a frequent target of the CTL response in persistently infected rhesus macaques.
    Fogg MH; Garry D; Awad A; Wang F; Kaur A
    J Immunol; 2006 Mar; 176(6):3391-401. PubMed ID: 16517707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus.
    Argaet VP; Schmidt CW; Burrows SR; Silins SL; Kurilla MG; Doolan DL; Suhrbier A; Moss DJ; Kieff E; Sculley TB; Misko IS
    J Exp Med; 1994 Dec; 180(6):2335-40. PubMed ID: 7964506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of Epstein-Barr virus-specific cytotoxic T lymphocytes to lyse B cells transformed with the B95-8 strain is mapped to an epitope that associates with the HLA-B8 antigen.
    Misko IS; Schmidt C; Honeyman M; Soszynski TD; Sculley TB; Burrows SR; Moss DJ; Burman K
    Clin Exp Immunol; 1992 Jan; 87(1):65-70. PubMed ID: 1370774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
    Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
    Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection and long-term persistence of reactive CTL clones during an EBV chronic response are determined by avidity, CD8 variable contribution compensating for differences in TCR affinities.
    Couedel C; Bodinier M; Peyrat MA; Bonneville M; Davodeau F; Lang F
    J Immunol; 1999 Jun; 162(11):6351-8. PubMed ID: 10352247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy.
    Wang Y; Aïssi-Rothe L; Virion JM; De Carvalho Bittencourt M; Ulas N; Audonnet S; Salmon A; Clement L; Venard V; Jeulin H; Stoltz JF; Decot V; Bensoussan D
    Cytotherapy; 2014 Jan; 16(1):122-34. PubMed ID: 24094498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
    Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
    Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.